- Home
- NREF vs ELDN Comparison
NREF vs ELDN Comparison
Compare NREF & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NREF
- ELDN
- Stock Information
- Founded
- NREF 2019
- ELDN 2004
- Country
- NREF United States
- ELDN United States
- Employees
- NREF N/A
- ELDN N/A
- Industry
- NREF Real Estate Investment Trusts
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- NREF Real Estate
- ELDN Health Care
- Exchange
- NREF Nasdaq
- ELDN Nasdaq
- Market Cap
- NREF 275.2M
- ELDN 232.4M
- IPO Year
- NREF 2020
- ELDN N/A
- Fundamental
- Price
- NREF $15.27
- ELDN $3.39
- Analyst Decision
- NREF Hold
- ELDN Strong Buy
- Analyst Count
- NREF 4
- ELDN 1
- Target Price
- NREF $15.00
- ELDN $16.00
- AVG Volume (30 Days)
- NREF 47.3K
- ELDN 261.8K
- Earning Date
- NREF 05-01-2025
- ELDN 03-20-2025
- Dividend Yield
- NREF 13.10%
- ELDN N/A
- EPS Growth
- NREF 69.45
- ELDN N/A
- EPS
- NREF 1.02
- ELDN N/A
- Revenue
- NREF $73,091,000.00
- ELDN N/A
- Revenue This Year
- NREF $53.67
- ELDN N/A
- Revenue Next Year
- NREF $43.59
- ELDN N/A
- P/E Ratio
- NREF $15.02
- ELDN N/A
- Revenue Growth
- NREF 73.65
- ELDN N/A
- 52 Week Low
- NREF $12.63
- ELDN $1.52
- 52 Week High
- NREF $18.09
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- NREF 39.72
- ELDN 32.13
- Support Level
- NREF $14.50
- ELDN $3.22
- Resistance Level
- NREF $16.80
- ELDN $3.44
- Average True Range (ATR)
- NREF 0.61
- ELDN 0.18
- MACD
- NREF -0.09
- ELDN -0.01
- Stochastic Oscillator
- NREF 33.48
- ELDN 20.31
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. It provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.